Zanubrutinib is Effective in Non-Germinal-center B-cell-like Diffuse Large B-cell Lymphoma with Mutated CD79B, High TCL1A Expression, or Over- Expressed MYC/BCL-2.
Leukemia & lymphoma/Leukemia and lymphoma（2024）
Key words
Diffuse large B-cell lymphoma,CD79B,TCL1A,MYC/BCL-2,zanubrutinib,biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined